Expert Insights On Decentralized Trials

  1. How To Turn Your Clinical Supply Chain Pandemic Learnings Into New Best Practices 3/10/2022

    Pivoting, navigating, and problem solving in real time during the pandemic has led to many real-time lessons that have evolved into adapted best practices in the global clinical supply space. This article discusses the new demand curve, packaging operations, IRT considerations, and more.

  2. Trends In Decentralized Clinical Trial Remote Monitoring For Medication Adherence 2/23/2022

    With the implementation of real-time remote monitoring technology, pharmas will be able to do more remote studies that require clinical trial patients to visit sites less frequently. This will remove the burden on patients and improve patient recruitment and retention. This article focuses on the patient medication adherence market.

  3. Patient Diversity In Clinical Studies: The Key To Advancing Precision Medicine 2/22/2022

    Until we have better inclusion of participants with diverse demographics and behaviors – and can analyze that data – we won’t know the effectiveness of a product for these patients. This article shares the barriers to patient diversity in traditional studies, the efforts that the authors' company is putting forth, and considerations to keep in mind.

  4. Explosive Investment In Virtual Trial Companies: The Latest Data 1/20/2022

    This article looks at the blossoming ecosystem and investment growth in the virtual trial space, specifically virtual trial companies that are foregoing the legacy clinical trial models and leveraging new technologies. Further, the article explores the power of the virtual trial platform and the key areas life sciences companies should consider when working with these virtual partners.

  5. Digitally Enabled Clinical Trials: A Practical Guide 12/2/2021

    Undoubtedly, digital trials will stay as the world coexists with the pandemic, so it is essential for both sponsors and sites to be early adopters. This article will examine the benefits and challenges of digital clinical trials and identify key considerations for sponsors and sites as the world continues to navigate the new normal.

  6. Decentralized Clinical Trials: Data Considerations & Value-Added Taxes 11/23/2021

    The rapidly changing regulatory, tax, and global business landscape, driven in part by COVID-19 and ongoing economic and political shifts, means that biopharma executives must keep careful watch over how they implement and monitor decentralized clinical trials (DCTs). This article examines key considerations for biopharma executives in overseeing hybrid or fully decentralized clinical trials.

  7. Digital Vs. Decentralized Trials: What's The Difference & How Do I Meet Implementation Challenges? 11/18/2021

    Digital clinical trials, which have gained momentum since the onset of the pandemic, have the potential to address many of the inefficiencies of traditional trials. This article defines digital clinical trials and how they differ from decentralized clinical trials, as well as how to meet implementation challenges.

  8. Is A Decentralized Clinical Trial Right For Your Trial? & 5 Tips For Success 11/11/2021

    Pharmaceutical companies have achieved considerable success in decentralizing clinical trials and shown that this model can offer significant benefits — both during the pandemic and afterward. While some elements of decentralization can be applied across all trial types, this article covers several specific trial characteristics that are particularly suited to remote studies, as well as tips to maximize success.

  9. How Biopharmas And CROs Can Create Value In Decentralized Global Trials 11/2/2021

    The need for biopharma execs to effectively engage CROs in decentralized clinical trials will only increase in the years to come. This article examines the results of a recent Ernst & Young (EY) study and also offers some recommendations for sponsors and CROs to be more effective with decentralized trials.

  10. Decentralized Clinical Trials: What Are The Opportunities For Data & Cost Savings? 10/19/2021

    Among our industry, sentiment remains positive that decentralized clinical trial models will improve patient centricity and reduce time to market for critical treatments, among other benefits. However, let's take a closer look at this transition to a more decentralized method, focusing in on the opportunities for data and cost savings.